NFE2L2 and myeloid sarcoma: Given that our experimental findings suggest that sustained Nrf2 activation and poor cholesterol pathway activation in astrocytes leads to oligodendrocyte death in demyelinated lesions, we asked whether the association could also be made in MS lesions.